Metronidazole Intravenous Iv Generics - Manufacturers & Suppliers
Flagyl(US)
| Product/Composition:- | Metronidazole intravenous IV |
|---|---|
| Strength:- | 500 mg/100 mL, 1 g/100 mL |
| Form:- | Intravenous (IV) |
| Reference Brands:- | Flagyl(US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Metronidazole IV inhibits bacterial and protozoal DNA synthesis by disrupting nucleic acid structures. It provides rapid, effective treatment for severe anaerobic infections, abscesses, and protozoal diseases. Benefits include quick bacterial eradication, good tissue penetration, and use in critical care when oral therapy isn’t feasible.
Metronidazole IV is approved in the EU and US for serious anaerobic bacterial and protozoal infections. In the EU, brands like Flagyl IV are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial data, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for metronidazole IV, ensuring adherence to European and US standards for safe, effective antimicrobial therapy in severe infections.